Quantcast
Last updated on May 23, 2013 at 19:51 EDT

Latest Glycoproteins Stories

2012-05-17 23:02:40

The ever-increasing popularity of the hCG weight loss diet has triggered various misconceptions and myths about precisely how hCG is made. A recent query posed to HCGBlog.com read, "Is hCG gathered from aborted babies?" In an effort to clarify this disturbing question and various other myths, HCGBlog.com explains exactly how hCG diet drops and injections are made. (PRWEB) May 17, 2012 An alarming myth has recently emerged that suggests that the human chorionic gonadotropin hCG...

2012-05-16 06:26:53

NEW YORK, May 16, 2012 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases, today announced it has filed three new patent applications with the United States Patent and Trademark Office (USPTO), which expand the Company's immunotherapy pipeline. (Logo:...

2012-05-08 09:45:39

Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections. The finding opens the way for the development of vaccines that can work more efficiently and hints at therapies for conditions in which B cells cause harm—such as the autoimmune disease lupus erythymatosus, severe allergies, and B-cell lymphomas. The discovery reveals that B cells produce special proteins to...

2012-05-08 02:28:08

SAN FRANCISCO, May 8, 2012 /PRNewswire/ -- Sutro Biopharma today announced the closing of the $16.5 million second tranche of its Series C financing. This financing was led by Skyline Ventures and included participation of Lilly Ventures, Amgen Ventures, SV Life Sciences and Alta Partners. With the Series C funding, Sutro has raised almost $60 million since its founding in 2003. "We are pleased with the great progress Sutro has made in developing its next generation antibody drug...

2012-05-04 23:00:22

HCG Blog answers 5 of the most popular hCG weight loss questions based on this week’s Google reports of the most popular search queries. (PRWEB) May 04, 2012 With so many news stories and conflicting opinions regarding hCG and the hCG weight loss diet, consumers are becoming increasingly confused about hCG. Upon reviewing the recent “most popular search queries” according to Google, http://www.hcgblog.com answers 5 of the most popular hCG weight loss questions. 1. “Where can I buy...

2012-04-30 06:24:44

THUNDER BAY, Ontario, April 30, 2012 /PRNewswire/ -- IGY Immune Technology & Life Sciences has acquired manufacturing capabilities to produce its proprietary IgY products. IgY from chicken egg yolks has long been recognized among scientists for its immune enhancing benefits in humans as well as its ability to deliver customized antibodies to fight sickness and maintain good health. Until now, a consistent, purified source has not been available commercially. IGY Immune...

2012-04-27 23:00:20

Losing weight and staying healthy may affect more than one's own health and well-being; an April study published in Pediatrics links autism with obesity during pregnancy. In response to this recent study, hCG Blog describes how using hCG drops to reach a healthy weight before becoming pregnant is an easy way for women to reduce the risk of birthing a child with autism or other developmental delays. (PRWEB) April 27, 2012 According to "Maternal Metabolic Conditions and Risk for Autism...

2012-04-27 06:23:30

WALTHAM, Mass., April 27, 2012 /PRNewswire/ -- X-BODY BioSciences, Inc., a developer of monoclonal antibody therapeutics, today announced it will present novel methods of selecting for antibodies against targets on the surface of live cells at CHI's Protein Engineering Summit (PEGS) and the associated Biologics Partnering Forum being held April 28th through May 4th in Boston, Massachusetts. Richard Wagner, Ph.D., Co-Founder and Executive Chairman of X-BODY, will present a talk...

2012-04-27 05:31:18

(Ivanhoe Newswire) -- Alzheimer’s disease (AD) is the leading cause of dementia in the elderly and is an incurable disease that affects more than five million people. Now intravenous human immunoglobulin (IVIG) treatment is currently being explored for uses other than immunotherapy, including AD. Several studies are assessing the tolerability and efficacy of IVIG in Alzheimer’s patients. Recent studies by Dr. Giulio Maria Pasinetti, Saunders Family Chair and Professor in Neurology and...

2012-04-22 23:01:25

Leading secondary reagents supplier offers secondary antibody conjugates West Grove, PA (PRWEB) April 22, 2012 Leading secondary antibodies supplier, Jackson ImmunoResearch, has new secondary antibody conjugates made with a selection of Alexa Fluor® dyes from Life Technologies. This offering includes AffiniPure antibodies and other proteins conjugated with Alexa Fluor® 647, Alexa Fluor® 594, and the very bright Alexa Fluor® 488. Each product table now lists the Alexa...